AVIENT CORP (AVNT) Q3 2025 10-Q Quarterly Report
Filed: Nov 5, 2025Period ending Sep 30, 2025
Health Care
Plastic Materials, Synth Resins & Nonvulcan ElastomersSEC EDGAR AVIENT CORP (AVNT) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AVIENT CORP Q3 2025 10-Q Analysis
Risk Factors
- • Newly added risk: Increased foreign trade policy risks triggered by U.S. tariffs and retaliatory actions by other countries impacting global demand
- • Most materially updated risk: Tariffs and trade barriers from U.S. policy changes heightening restrictions and economic disincentives on international trade
AVIENT CORP Q3 2025 Quarterly FinancialsXBRL
Revenue
$807M
▼ -1.1% YoY▼ -6.9% QoQ
Net Income
$33M
▼ -14.7% YoY▼ -38.0% QoQ
Gross Margin
30.4%
▼ -170bp YoY▼ -171bp QoQ
Operating Margin
8.3%
▼ -115bp YoY▼ -277bp QoQ
Net Margin
4.0%
▼ -64bp YoY▼ -203bp QoQ
ROE
1.4%
Total Assets
$6.1B
EPS (Diluted)
$0.36
▼ -14.3% YoY▼ -36.8% QoQ
Operating Cash Flow
$72M
▲ +1.4% YoY▼ -36.1% QoQ
Source: XBRL data from AVIENT CORP Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on AVIENT CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.